Mundipharma
Generated by Meeveem AI
"Global pharmaceutical company transforming cancer pain management and specialty care"
About Mundipharma
Mundipharma develops and delivers medicines with a focus on cancer pain management and specialty care. Its therapeutic areas include oncology, respiratory medicine, biosimilars and anti-infectives, alongside central nervous system and ophthalmology treatments. Founded in 1952, the company has its global headquarters at Cambridge Science Park.
Its international network describes a reach across 120 countries, working with healthcare practitioners, caregivers and partners. Mundipharma combines experience in late-stage development and global clinical trials with commercial, manufacturing and supply capabilities. The business is undergoing a global transformation, while its teams work to bring medicines from development through regulatory approval and into patient care.
Learning and career development
Mundipharma’s global learning portfolio includes MundiLearn, mentoring, coaching and career planning, together with a Development Week. Its approach covers professional development across the workforce, with separate programmes for emerging talent and colleagues preparing for senior roles.
Working across teams
The company uses global town halls with live questions, an intranet carrying country and functional updates, and an internal social network for colleagues to share knowledge. These channels connect teams across countries and disciplines rather than relying only on local communication.
3600
Team Members
1952
Founded
Pharma
Sector
Hybrid
Work Environment